1
Pharmacodynamics and pharmacokinetics of nalbuphine in xylazine‑sedated horses
VetIt.2408.16506.1

Keywords

Horses
Nalbuphine
Pharmacodynamics
Pharmacokinetics
Xylazine

How to Cite

Hammad, A., Gadallah, S. ., Misk, T. ., Sharshar, A. ., Thabet, N., & Mourad, A. (2023). Pharmacodynamics and pharmacokinetics of nalbuphine in xylazine‑sedated horses. Veterinaria Italiana, 58(3). https://doi.org/10.12834/VetIt.2408.16506.1

Abstract

This study describes the selected pharmacodynamics and pharmacokinetics of nalbuphine (NAL) in xylazine (XYL)‑sedated horses. Five adult healthy horses were randomly received 2 treatments at a 1‑week interval; XYL treatment (0.55 mg/kg IV) and XYL/NAL treatment (XYL, 0.55 mg/kg IV; NAL, 0.3 mg/kg IV). The measured pharmacodynamic variables were sedative and analgesic effects and the effect on ataxia and some physiological parameters. for the pharmacokinetics of NAL, its plasma concentrations were measured using HPLC and a 2‑compartment analysis was performed. Greater and prolonged sedation was evident after XYL/NAL treatment compared with XYL treatment. Slightly improved and prolonged analgesia was demonstrated after XYL/NAL treatment. Significant changes in blood pressure and respiratory rate lasted for a shorter duration with XYL/NAL treatment than with XYL treatment. After XYL treatment, rectal temperature was significantly different from baseline and XYL/NAL treatment. Elimination half‑life of NAL was 3.47 ± 1.39 hours and total body clearance was 2.88 ± 0.73 L/kg/hour. In conclusion, addition of NAL to XYL resulted in remarkable advantages on the measured parameters. The obtained pharmacokinetics of NAL could be useful in determining the effective NAL infusion rate, which could be further evaluated as an adjunctive agent to XYL for prolonged sedation in horses.

https://doi.org/10.12834/VetIt.2408.16506.1
VetIt.2408.16506.1

References

Aitkenhead A.R., Lin E.S. & Achola K.J. 1988. The pharmacokinetics of oral and intravenous nalbuphine in healthy volunteers. Br J Clin Pharmacol, 25, 264-268.

Alitalo A. 1986. Clinical experiences with Domosedan in horses and cattle. Acta Vet Scand, 82, 193-196.

Baggot J.D. 1978. Some aspects of clinical pharmacokinetics in veterinary medicine. Int J Vet Pharmacol Ther, 1, 5-18.

Brunson D.B. & Majors L.J. 1987. Comparative analgesia of xylazine, xylazine/morphine, xylazine/butorphanol, and xylazine/nalbuphine in the horse, using dental dolorimetry. Am J Vet Res, 48, 1087-1091.

Bueno A.C., Cornick-Seahorn J., Seahorn T.L., Hosgood G. & Moore R.M. 1999. Cardiopulmonary and sedative effects of intravenous administration of low doses of medetomidine and xylazine to adult horses. Am J Vet Res, 60, 1371-1376.

Bugedo G. & Torregrosa S. 1995. Postoperative analgesia. Bulletin School of Medicine, Pontificia, Universidad Católica de Chile, Santiago, Chile.

Clarke K.W., England G.C.W. & Goossens L. 1991. Sedative and cardiovascular effects of Romifidine, alone and in combination with butorphanol, in the horse. J Vet Anaesth, 18, 25-29.

Clutton R.E. 2010. Opioid analgesia in horses. Vet Clin Equine, 26, 493-514.

Coetzee J.F., Lechtenberg K.F., Stock M.L. & KuKanich B. 2014. Pharmacokinetics and effect of intravenous nalbuphine in weaned Holstein calves after surgical castration. J Vet Pharmacol Ther, 37, 169-177.

Corletto F., Raisis A.A. & Brearley J.C. 2005. Comparison of morphine and butorphanol as pre-anaesthetic agents in combination with Romifidine for field castration in ponies. Vet Anaesth Analg, 32, 16-22.

DeRossi R., Jorge T.P., Ossuna M.R., Carneiro R.P.B., Alves O.D. & Zanenga N.F. 2009. Sedation and pain management with intravenous romifidine−butorphanol in standing horses. J Equine Vet Sci, 29, 75-81.

Dhanjal J.K., Wilson D.V., Robinson E., Tobin T.T., Dirikolu L. & Dirokulu L. 2009. Intravenous tramadol: effects, nociceptive properties, and pharmacokinetics in horses. Vet Anaesth Analg, 36, 581-590.

Dugdale A. 2010. Equine sedation and premedication. Veterinary anaesthesia principles to practice. Wiley, Blackwell, Oxford, United Kingdom, 252-254.

England G.C., Clarke K.W. & Goossens L. 1992. A comparison of the sedative effects of three alpha 2-adrenoceptor agonists (Romifidine, detomidine and xylazine) in the horse. J Vet Pharmacol Ther, 15, 194-201.

Fernandes de Souza J.F., Raposo Monteiro E.R., Campagnol D., Ramos R.C. & Frasson A.M.F. 2012. Evaluation of nociception, sedation, and cardiorespiratory effects of a constant rate infusion of xylazine alone or in combination with lidocaine in horses. J Equine Vet Sci, 32, 339-345.

Gozalo-Marcilla M., Luna S.P., Crosignani N., Filho J.N.P., Possebon F.S., Pelligand L. & Taylor P.M. 2017. Sedative and antinociceptive effects of different combinations of detomidine and methadone in standing horses. Vet Anaesth Analg, 44, 1116-1127.

Guilhen R.C., Cassu R.N., Diniz M.S., Giuffrida R. & Duarte R.R. 2015. A comparison of detomidine in combination with saline, morphine or methadone in horses submitted to experimental oral stimuli. Semin Cienc Agr, 36, 4225-4235.

Huang P.W., Liu H.T., Hsiong C.H., Pao L.H., Lu C.C., Ho S.T. & Hu O.Y. 2013. Simultaneous determination of nalbuphine and its prodrug sebacoly dinalbuphine ester in human plasma by ultra-performance liquid chromatography–tandem mass spectrometry and its application to pharmacokinetic study in humans. Biomed. Chromatographia, 27, 831-837.

Hubbell J.A.E. 2009. Practical Standing Chemical Restraint of the Horse: anaesthesia and pain management. 55th Proceedings of the annual convention of AAEP, 2-6.

Kulkarni H., William B.J., George R.S. & Kannan T.A. 2015. Analgesic and adjunct actions of nalbuphine hydrochloride in xylazine or xylazine and acepromazine premedicated horses. Indian J Anim Res, 49, 699-703.

Love E.J., Taylor P.M., Murrell J., Whay H.R. & Waterman-Pearson A.E. 2011. Assessment of the sedative effects of buprenorphine administered with 20 microg/kg detomidine in horses. Vet Rec, 168, 409.

Peştean C., Oana L., Ober C., Miclăuş V. & Oros D. 2010. Assessment of the sedative effects of xylazine, detomidine and Romifidine in horses. Annals RSCB, 15, 282-284.

Queiroz-Neto A., Zamur G., Gonçalves S.C., Carregaro A.B., Mataqueiro M.I., Harkins J.D. & Tobin T. 1998. Characterization of the antinociceptive and sedative effect of amitraz in horses. J Vet Pharmacol Ther, 21, 400-405.

Rezende M.L., Grimsrud K.N., Stanley S.D., Steffey E.P. & Mama K.R. 2015. Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in the horse. J Vet Pharmacol Ther, 38, 15-23.

Ringer S.K., Portier K., Torgerson P.R., Castagno R. & Bettschart-Wolfensberger R. 2013. The effects of a loading dose followed by constant rate infusion of xylazine compared with Romifidine on sedation, ataxia and response to stimuli in horses. Vet Anaesth Analg, 40, 157-165.

Ringer S.K., Portier K.G., Fourel I. & Bettschart-Wolfensberger R. 2012. Development of a xylazine constant rate infusion with or without butorphanol for standing sedation of horses. Vet Anaesth Analg, 39, 1-11.

Ruiz J., Zuluaga D., Ruiz I., Duque D., Ochoa M. & Escobar T. 2015. Evaluation of sedation and analgesia protocols with xylazine and two rates of morphine by continuous infusion in stationary horses undergoing laparoscopic castration. Arch Med Vet, 47, 333-340.

Santonastaso A., Hardy J., Cohen N. & Fajt V. 2014. Pharmacokinetics and pharmacodynamics of xylazine administered by the intravenous or intra-osseous route in adult horses. J Vet Pharmacol Ther, 37,565-570.

Schauvliege S., Cuypers C., Michielsen A., Gasthuys F. & Gozalo-Marcilla M. 2019. How to score sedation and adjust the administration rate of sedatives in horses: a literature review and introduction of the Ghent Sedation Algorithm. Vet Anaesth Analg, 46, 4-13.

Sellon D.C., Monroe V.L., Roberts M.C. & Papich M.G. 2001. Pharmacokinetics and adverse effects of butorphanol administered by single intravenous injection or continuous intravenous infusion in horses. Am J Vet Res, 62, 183-189.

Seo J.P., Son W.G., Gang S. & Lee I. 2011. Sedative and analgesic effects of intravenous xylazine and tramadol on horses. J Vet Sci, 12, 281-286.

Sinclair M.D. 2003. A review of the physiological effects of alpha2-agonists related to the clinical use of medetomidine in small animal practice. Can Vet J, 44, 885-897.

Solano A.M., Valverde A., Desrochers A., Nykamp S. & Boure L.P. 2009. Behavioural and cardiorespiratory effects of a constant rate infusion of medetomidine and morphine for sedation during standing laparoscopy in horses. Equine Vet J, 41, 153-159.

Taylor P.M., Rymaszewska H. & Young S.S. 1990. Evaluation of combinations of nalbuphine with acepromazine or detomidine for sedation in ponies. J Ass Vet Anaesth, 17, 38-41.

Wagner A.E., Mama K.R., Contino E.K., Ferris D.J. & Kawcak C.E. 2011. Evaluation of sedation and analgesia in standing horses after administration of xylazine, butorphanol, and subanesthetic doses of ketamine. J Am Vet Med Assoc, 238, 1629-1633.

Copyright (c) 2023 Amal Hammad, Shaaban Gadallah, Tarek Misk, Ahmed Sharshar, Nahed Thabet, Ahmed Mourad